Cargando…
Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer
BACKGROUND: The biological function of protein arginine methyltransferase 3 (PRMT3) is not well known because very few physiological substrates of this methyltransferase have been identified to date. METHODS: The clinical significance of PRMT3 in pancreatic cancer was studied by database analysis. T...
Autores principales: | Hsu, Ming-Chuan, Tsai, Ya-Li, Lin, Chia-Hsien, Pan, Mei-Ren, Shan, Yan-Shen, Cheng, Tsung-Yen, Cheng, Skye Hung-Chun, Chen, Li-Tzong, Hung, Wen-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642535/ https://www.ncbi.nlm.nih.gov/pubmed/31324208 http://dx.doi.org/10.1186/s13045-019-0769-7 |
Ejemplares similares
-
Protein Arginine Methyltransferase 3 Enhances Chemoresistance in Pancreatic Cancer by Methylating hnRNPA1 to Increase ABCG2 Expression
por: Hsu, Ming-Chuan, et al.
Publicado: (2018) -
The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer
por: Pan, Mei-Ren, et al.
Publicado: (2016) -
The Critical Role of Protein Arginine Methyltransferase prmt8 in Zebrafish Embryonic and Neural Development Is Non-Redundant with Its Paralogue prmt1
por: Lin, Yu-ling, et al.
Publicado: (2013) -
Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma
por: Nguyen, Hong Phuong, et al.
Publicado: (2023) -
Corrigendum: Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma
por: Nguyen, Hong Phuong, et al.
Publicado: (2023)